IDO1 Antikörper

Produktnummer ABIN1043733

Hersteller Produkt- Nr.: 200-301-e57

Produktdetails anti-IDO1 Antikörper

Target: IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Reaktivität: Human, Maus

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser IDO1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP), Fluorescence Microscopy (FM)

Hersteller Produkt- Nr.: 200-301-e57

Hersteller: Rockland

Verwendungszweck: IDO1 Antibody

Kreuzreaktivität (Details): This antibody is specific for human and mouse IDO1 protein.

Produktmerkmale: Synonyms: mouse anti-IDO1 antibody, Ido antibody, Indo, Indoleamine 2,3-dioxygenase 1, Indoleamine-pyrrole 2,3-dioxygenase, Ido1, Ido-1

Aufreinigung: Anti-IDO1 was purified from concentrated tissue culture supernate by Protein G chromatography followed by extensive dialysis against the buffer stated above.

Sterilität: Sterile filtered

Immunogen:

Immunogen: Anti-IDO1 (MOUSE) Monoclonal Antibody was produced in mouse by repeated immunizations with fragment of recombinant human and mouse IDO1 protein followed by hybridoma development.

Immunogen Type: Recombinant Protein

Klon: 10-1

Isotyp: IgG3

Anwendungsinformationen

Applikationshinweise:

Immunohistochemistry Dilution: 1:100-1:500

Application Note: Anti-IDO1 antibody has been tested in ELISA, IP, and Western Blot. This antibody is suitable for use in IHC and Flow Cytometry. Specific conditions for reactivity should be optimized by the end user.

Western Blot Dilution: 1:500-1:1500

Immunoprecipitation Dilution: 10-100 μL

ELISA Dilution: 1:5000-1:50000

IF Microscopy Dilution: 1:50-1:100

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.0 mg/mL

Buffer:

Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

Stabilizer: None

Preservative: 0.01 % (w/v) Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

Haltbarkeit: 12 months

Referenzen für anti-IDO1 Antikörper (ABIN1043733)

Meyer, Klatte, Dinh, Harries, Reithmayer, Meyer, Sinclair, Paus: "Evidence that the bulge region is a site of relative immune privilege in human hair follicles." in: The British journal of dermatology, Vol. 159, Issue 5, pp. 1077-85, (2009) (PubMed).

Batista, Juhász, Muzik, Kupsky, Barger, Chugani, Mittal, Sood, Chakraborty, Chugani: "Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors." in: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, Vol. 11, Issue 6, pp. 460-6, (2009) (PubMed).

Zhu, Ji, Wang, Zhang, Liu, Zhang, Matsushima, Cao, Zhang: "Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 177, Issue 11, pp. 8226-33, (2007) (PubMed).

Mellor, Munn: "IDO expression by dendritic cells: tolerance and tryptophan catabolism." in: Nature reviews. Immunology, Vol. 4, Issue 10, pp. 762-74, (2004) (PubMed).

Details zu IDO1

Target: IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Andere Bezeichnung: Ido1 (IDO1 Produkte)

Hintergrund: Background: Indoleamine 2, 3-dioxygenase1 (IDO1) is a 41-42 kD intracellular enzyme that catabolizes tryptophan into kynurenine. IDO1 modulates levels of the amino acid tryptophan, which is vital for cell growth, but is also involved in the suppression of the immune response. IDO1 effects on immune suppression are due to decreased tryptophan availability and the generation of tryptophan metabolites, resulting in negative effects on T lymphocytes, including proliferation, function and survival. IDO1 may be involved in the suppression of the immune response to tumors, and blocking the IDO1 pathway may be a potential target for immuno and cancer therapy. IDO1 is expressed in a wide variety of tissues and can be upregulated by interferon gamma and other inflammatory cytokines.

Gen-ID: 3620

NCBI Accession: NP_002155

UniProt: P14902

Pathways: Activated T Cell Proliferation